4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-108403
Director sold 80,293 shares at an average $36.15 ($2,902,720)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-09-18 | Sale 10b5-1 | −1,554 | $35.03 | $54,437 | 392,277 | I |
| Kersten Dirk Director | 2024-09-19 | Sale 10b5-1 | −27,767 | $35.74 | $992,393 | 364,510 | I |
| Kersten Dirk Director | 2024-09-19 | Sale 10b5-1 | −50,972 | $36.41 | $1,855,891 | 313,538 | I |
| Open-market sales · 80,293 sh · avg $36.15 · $2,902,720 | |||||||
Loading xslF345X05/ownership.xml…